Evolus Statistics
Total Valuation
Evolus has a market cap or net worth of $797.85 million. The enterprise value is $842.69 million.
Important Dates
The last earnings date was Wednesday, November 6, 2024, after market close.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Evolus has 63.32 million shares outstanding. The number of shares has increased by 6.72% in one year.
| Current Share Class | 63.32M |
| Shares Outstanding | 63.32M |
| Shares Change (YoY) | +6.72% |
| Shares Change (QoQ) | +0.68% |
| Owned by Insiders (%) | 1.98% |
| Owned by Institutions (%) | 71.97% |
| Float | 49.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 143.05 |
| PS Ratio | 3.07 |
| Forward PS | n/a |
| PB Ratio | 135.31 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.39 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.47, with a Debt / Equity ratio of 22.05.
| Current Ratio | 2.47 |
| Quick Ratio | 2.13 |
| Debt / Equity | 22.05 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.73 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -9.93% |
| Return on Capital (ROIC) | -18.11% |
| Revenue Per Employee | $909,619 |
| Profits Per Employee | -$203,150 |
| Employee Count | 273 |
| Asset Turnover | 1.25 |
| Inventory Turnover | 4.59 |
Taxes
In the past 12 months, Evolus has paid $330,000 in taxes.
| Income Tax | 330,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +33.76% in the last 52 weeks. The beta is 1.31, so Evolus's price volatility has been higher than the market average.
| Beta (5Y) | 1.31 |
| 52-Week Price Change | +33.76% |
| 50-Day Moving Average | 15.58 |
| 200-Day Moving Average | 13.73 |
| Relative Strength Index (RSI) | 35.61 |
| Average Volume (20 Days) | 714,863 |
Short Selling Information
The latest short interest is 5.43 million, so 8.58% of the outstanding shares have been sold short.
| Short Interest | 5.43M |
| Short Previous Month | 4.99M |
| Short % of Shares Out | 8.58% |
| Short % of Float | 10.96% |
| Short Ratio (days to cover) | 10.23 |
Income Statement
In the last 12 months, Evolus had revenue of $248.33 million and -$55.46 million in losses. Loss per share was -$0.92.
| Revenue | 248.33M |
| Gross Profit | 173.69M |
| Operating Income | -31.57M |
| Pretax Income | -52.99M |
| Net Income | -55.46M |
| EBITDA | -26.27M |
| EBIT | -31.57M |
| Loss Per Share | -$0.92 |
Full Income StatementBalance Sheet
The company has $85.04 million in cash and $129.88 million in debt, giving a net cash position of -$44.84 million or -$0.71 per share.
| Cash & Cash Equivalents | 85.04M |
| Total Debt | 129.88M |
| Net Cash | -44.84M |
| Net Cash Per Share | -$0.71 |
| Equity (Book Value) | 5.89M |
| Book Value Per Share | 0.09 |
| Working Capital | 89.55M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$21.99 million and capital expenditures -$1.24 million, giving a free cash flow of -$23.24 million.
| Operating Cash Flow | -21.99M |
| Capital Expenditures | -1.24M |
| Free Cash Flow | -23.24M |
| FCF Per Share | -$0.37 |
Full Cash Flow StatementMargins
Gross margin is 69.94%, with operating and profit margins of -12.71% and -22.33%.
| Gross Margin | 69.94% |
| Operating Margin | -12.71% |
| Pretax Margin | -22.20% |
| Profit Margin | -22.33% |
| EBITDA Margin | -10.58% |
| EBIT Margin | -12.71% |
| FCF Margin | -8.49% |
Dividends & Yields
Evolus does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.72% |
| Shareholder Yield | -6.72% |
| Earnings Yield | -6.95% |
| FCF Yield | -2.91% |
Analyst Forecast
The average price target for Evolus is $22.60, which is 79.37% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $22.60 |
| Price Target Difference | 79.37% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 27.72% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Evolus has an Altman Z-Score of -0.62 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.62 |
| Piotroski F-Score | 4 |